nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—Hydrocortisone—ulcerative colitis	0.306	1	CrCtD
Drospirenone—PTGS2—ulcerative colitis	0.109	1	CbGaD
Drospirenone—NR3C2—Betamethasone—ulcerative colitis	0.0407	0.151	CbGbCtD
Drospirenone—NR3C2—Prednisolone—ulcerative colitis	0.0402	0.149	CbGbCtD
Drospirenone—PTGS2—Olsalazine—ulcerative colitis	0.0277	0.103	CbGbCtD
Drospirenone—PGR—Betamethasone—ulcerative colitis	0.0263	0.0974	CbGbCtD
Drospirenone—PTGS2—Balsalazide—ulcerative colitis	0.0247	0.0917	CbGbCtD
Drospirenone—NR3C2—Dexamethasone—ulcerative colitis	0.0237	0.0877	CbGbCtD
Drospirenone—PTGS2—Mesalazine—ulcerative colitis	0.0198	0.0733	CbGbCtD
Drospirenone—PGR—Dexamethasone—ulcerative colitis	0.0153	0.0567	CbGbCtD
Drospirenone—BCHE—Triamcinolone—ulcerative colitis	0.0144	0.0532	CbGbCtD
Drospirenone—Flurandrenolide—Budesonide—ulcerative colitis	0.0128	0.047	CrCrCtD
Drospirenone—Testolactone—Budesonide—ulcerative colitis	0.0112	0.0413	CrCrCtD
Drospirenone—PTGS2—Sulfasalazine—ulcerative colitis	0.011	0.0409	CbGbCtD
Drospirenone—PTGS2—Triamcinolone—ulcerative colitis	0.011	0.0409	CbGbCtD
Drospirenone—Eplerenone—Hydrocortisone—ulcerative colitis	0.011	0.0405	CrCrCtD
Drospirenone—PTGS2—Betamethasone—ulcerative colitis	0.00948	0.0351	CbGbCtD
Drospirenone—Formestane—Hydrocortisone—ulcerative colitis	0.00921	0.0339	CrCrCtD
Drospirenone—Potassium Canrenoate—Hydrocortisone—ulcerative colitis	0.00833	0.0306	CrCrCtD
Drospirenone—Spironolactone—Hydrocortisone—ulcerative colitis	0.00833	0.0306	CrCrCtD
Drospirenone—Hydrocortisone—Budesonide—ulcerative colitis	0.00821	0.0302	CrCrCtD
Drospirenone—Megestrol acetate—Hydrocortisone—ulcerative colitis	0.00762	0.028	CrCrCtD
Drospirenone—Potassium Canrenoate—Prednisone—ulcerative colitis	0.00717	0.0264	CrCrCtD
Drospirenone—Medrysone—Hydrocortisone—ulcerative colitis	0.00703	0.0259	CrCrCtD
Drospirenone—Potassium Canrenoate—Prednisolone—ulcerative colitis	0.007	0.0257	CrCrCtD
Drospirenone—Medroxyprogesterone Acetate—Hydrocortisone—ulcerative colitis	0.00678	0.0249	CrCrCtD
Drospirenone—Medrysone—Methylprednisolone—ulcerative colitis	0.00664	0.0244	CrCrCtD
Drospirenone—Flurandrenolide—Hydrocortisone—ulcerative colitis	0.00654	0.024	CrCrCtD
Drospirenone—Medroxyprogesterone Acetate—Methylprednisolone—ulcerative colitis	0.00639	0.0235	CrCrCtD
Drospirenone—Flurandrenolide—Methylprednisolone—ulcerative colitis	0.00617	0.0227	CrCrCtD
Drospirenone—Norethindrone—Hydrocortisone—ulcerative colitis	0.00612	0.0225	CrCrCtD
Drospirenone—Flurandrenolide—Betamethasone—ulcerative colitis	0.00607	0.0223	CrCrCtD
Drospirenone—Flurandrenolide—Dexamethasone—ulcerative colitis	0.00607	0.0223	CrCrCtD
Drospirenone—Cortisone acetate—Hydrocortisone—ulcerative colitis	0.00593	0.0218	CrCrCtD
Drospirenone—Medrysone—Prednisolone—ulcerative colitis	0.00591	0.0217	CrCrCtD
Drospirenone—Cortisone acetate—Methylprednisolone—ulcerative colitis	0.00559	0.0206	CrCrCtD
Drospirenone—PTGS2—Dexamethasone—ulcerative colitis	0.00551	0.0204	CbGbCtD
Drospirenone—Flurandrenolide—Prednisolone—ulcerative colitis	0.0055	0.0202	CrCrCtD
Drospirenone—Testolactone—Methylprednisolone—ulcerative colitis	0.00543	0.02	CrCrCtD
Drospirenone—Testolactone—Dexamethasone—ulcerative colitis	0.00534	0.0196	CrCrCtD
Drospirenone—Testolactone—Betamethasone—ulcerative colitis	0.00534	0.0196	CrCrCtD
Drospirenone—Testolactone—Triamcinolone—ulcerative colitis	0.00522	0.0192	CrCrCtD
Drospirenone—Testosterone Propionate—Hydrocortisone—ulcerative colitis	0.00515	0.0189	CrCrCtD
Drospirenone—Progesterone—Hydrocortisone—ulcerative colitis	0.00515	0.0189	CrCrCtD
Drospirenone—Cortisone acetate—Prednisone—ulcerative colitis	0.00511	0.0188	CrCrCtD
Drospirenone—Methyltestosterone—Hydrocortisone—ulcerative colitis	0.00502	0.0185	CrCrCtD
Drospirenone—Cortisone acetate—Prednisolone—ulcerative colitis	0.00498	0.0183	CrCrCtD
Drospirenone—Testolactone—Prednisone—ulcerative colitis	0.00495	0.0182	CrCrCtD
Drospirenone—Testolactone—Prednisolone—ulcerative colitis	0.00484	0.0178	CrCrCtD
Drospirenone—Testosterone—Hydrocortisone—ulcerative colitis	0.00447	0.0164	CrCrCtD
Drospirenone—Progesterone—Prednisolone—ulcerative colitis	0.00433	0.0159	CrCrCtD
Drospirenone—Methyltestosterone—Prednisone—ulcerative colitis	0.00432	0.0159	CrCrCtD
Drospirenone—Methyltestosterone—Prednisolone—ulcerative colitis	0.00422	0.0155	CrCrCtD
Drospirenone—Hydrocortisone—Methylprednisolone—ulcerative colitis	0.00396	0.0146	CrCrCtD
Drospirenone—Hydrocortisone—Betamethasone—ulcerative colitis	0.0039	0.0143	CrCrCtD
Drospirenone—Hydrocortisone—Dexamethasone—ulcerative colitis	0.0039	0.0143	CrCrCtD
Drospirenone—Hydrocortisone—Triamcinolone—ulcerative colitis	0.00381	0.014	CrCrCtD
Drospirenone—Testosterone—Prednisolone—ulcerative colitis	0.00376	0.0138	CrCrCtD
Drospirenone—Hydrocortisone—Prednisone—ulcerative colitis	0.00362	0.0133	CrCrCtD
Drospirenone—Hydrocortisone—Prednisolone—ulcerative colitis	0.00353	0.013	CrCrCtD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.000758	0.041	CbGpPWpGaD
Drospirenone—Infarction—Methylprednisolone—ulcerative colitis	0.000711	0.0334	CcSEcCtD
Drospirenone—PTGS2—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.000625	0.0338	CbGpPWpGaD
Drospirenone—PGR—Nuclear Receptors—NR5A2—ulcerative colitis	0.000584	0.0316	CbGpPWpGaD
Drospirenone—PGR—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.000461	0.025	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptors—NR5A2—ulcerative colitis	0.000445	0.0241	CbGpPWpGaD
Drospirenone—Embolism venous—Prednisolone—ulcerative colitis	0.000426	0.02	CcSEcCtD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.000423	0.0229	CbGpPWpGaD
Drospirenone—Thrombosis—Mesalazine—ulcerative colitis	0.000417	0.0196	CcSEcCtD
Drospirenone—Embolism venous—Hydrocortisone—ulcerative colitis	0.000416	0.0196	CcSEcCtD
Drospirenone—PGR—Cellular roles of Anthrax toxin—CALM3—ulcerative colitis	0.000405	0.0219	CbGpPWpGaD
Drospirenone—Embolism venous—Triamcinolone—ulcerative colitis	0.000392	0.0184	CcSEcCtD
Drospirenone—Embolism venous—Methylprednisolone—ulcerative colitis	0.000391	0.0184	CcSEcCtD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CHP1—ulcerative colitis	0.000379	0.0205	CbGpPWpGaD
Drospirenone—Affect lability—Nicotine—ulcerative colitis	0.000377	0.0177	CcSEcCtD
Drospirenone—Migraine—Nicotine—ulcerative colitis	0.000377	0.0177	CcSEcCtD
Drospirenone—Mood swings—Nicotine—ulcerative colitis	0.000363	0.0171	CcSEcCtD
Drospirenone—Breast disorder—Mercaptopurine—ulcerative colitis	0.000357	0.0168	CcSEcCtD
Drospirenone—Embolism venous—Dexamethasone—ulcerative colitis	0.000356	0.0167	CcSEcCtD
Drospirenone—Embolism venous—Betamethasone—ulcerative colitis	0.000356	0.0167	CcSEcCtD
Drospirenone—AR—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.000351	0.019	CbGpPWpGaD
Drospirenone—PGR—Cellular roles of Anthrax toxin—VCAM1—ulcerative colitis	0.000347	0.0188	CbGpPWpGaD
Drospirenone—Breast pain—Mesalazine—ulcerative colitis	0.000339	0.0159	CcSEcCtD
Drospirenone—Embolism—Prednisolone—ulcerative colitis	0.000335	0.0158	CcSEcCtD
Drospirenone—BCHE—Synthesis, secretion, and deacylation of Ghrelin—GHRL—ulcerative colitis	0.000327	0.0177	CbGpPWpGaD
Drospirenone—Embolism—Hydrocortisone—ulcerative colitis	0.000327	0.0154	CcSEcCtD
Drospirenone—PGR—Nuclear Receptors—HNF4A—ulcerative colitis	0.000326	0.0176	CbGpPWpGaD
Drospirenone—Embolism venous—Prednisone—ulcerative colitis	0.00031	0.0146	CcSEcCtD
Drospirenone—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000309	0.247	CbGdCrCtD
Drospirenone—AR—FOXA1 transcription factor network—COL18A1—ulcerative colitis	0.000309	0.0167	CbGpPWpGaD
Drospirenone—Embolism—Triamcinolone—ulcerative colitis	0.000308	0.0145	CcSEcCtD
Drospirenone—Embolism—Methylprednisolone—ulcerative colitis	0.000308	0.0145	CcSEcCtD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—COL18A1—ulcerative colitis	0.0003	0.0163	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.000285	0.0154	CbGpPWpGaD
Drospirenone—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—ulcerative colitis	0.000283	0.0153	CbGpPWpGaD
Drospirenone—Embolism—Dexamethasone—ulcerative colitis	0.00028	0.0132	CcSEcCtD
Drospirenone—Embolism—Betamethasone—ulcerative colitis	0.00028	0.0132	CcSEcCtD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.000264	0.0143	CbGpPWpGaD
Drospirenone—Migraine—Budesonide—ulcerative colitis	0.00026	0.0122	CcSEcCtD
Drospirenone—Affect lability—Budesonide—ulcerative colitis	0.00026	0.0122	CcSEcCtD
Drospirenone—PGR—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.000258	0.0139	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—ulcerative colitis	0.000257	0.0139	CbGpPWpGaD
Drospirenone—NR3C2—ACE Inhibitor Pathway—TGFB1—ulcerative colitis	0.000252	0.0136	CbGpPWpGaD
Drospirenone—Mood swings—Budesonide—ulcerative colitis	0.00025	0.0118	CcSEcCtD
Drospirenone—AR—Nuclear Receptors—HNF4A—ulcerative colitis	0.000249	0.0134	CbGpPWpGaD
Drospirenone—Embolism—Prednisone—ulcerative colitis	0.000244	0.0115	CcSEcCtD
Drospirenone—AR—Androgen receptor signaling pathway—PARK7—ulcerative colitis	0.000239	0.013	CbGpPWpGaD
Drospirenone—Breast disorder—Budesonide—ulcerative colitis	0.000238	0.0112	CcSEcCtD
Drospirenone—PGR—Ovarian Infertility Genes—VDR—ulcerative colitis	0.000233	0.0126	CbGpPWpGaD
Drospirenone—Mental disorder—Nicotine—ulcerative colitis	0.000232	0.0109	CcSEcCtD
Drospirenone—PTGS2—C-MYB transcription factor network—PRTN3—ulcerative colitis	0.000224	0.0121	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—PTGS1—ulcerative colitis	0.000222	0.012	CbGpPWpGaD
Drospirenone—Migraine—Mesalazine—ulcerative colitis	0.000211	0.00993	CcSEcCtD
Drospirenone—Affect lability—Mesalazine—ulcerative colitis	0.000211	0.00993	CcSEcCtD
Drospirenone—AR—Notch-mediated HES/HEY network—MAML2—ulcerative colitis	0.000204	0.0111	CbGpPWpGaD
Drospirenone—Mood swings—Mesalazine—ulcerative colitis	0.000203	0.00956	CcSEcCtD
Drospirenone—PGR—Nuclear Receptors—VDR—ulcerative colitis	0.000203	0.011	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—ulcerative colitis	0.000201	0.00946	CcSEcCtD
Drospirenone—AR—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.000196	0.0106	CbGpPWpGaD
Drospirenone—AR—Coregulation of Androgen receptor activity—TCF4—ulcerative colitis	0.000196	0.0106	CbGpPWpGaD
Drospirenone—Breast disorder—Mesalazine—ulcerative colitis	0.000194	0.00912	CcSEcCtD
Drospirenone—Skin disorder—Mercaptopurine—ulcerative colitis	0.000189	0.00887	CcSEcCtD
Drospirenone—Nervous system disorder—Nicotine—ulcerative colitis	0.000185	0.00868	CcSEcCtD
Drospirenone—PTGS2—Eicosanoid Synthesis—PTGS1—ulcerative colitis	0.000184	0.00995	CbGpPWpGaD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	0.000184	0.00994	CbGpPWpGaD
Drospirenone—Haemoglobin—Budesonide—ulcerative colitis	0.000183	0.00862	CcSEcCtD
Drospirenone—Haemorrhage—Budesonide—ulcerative colitis	0.000182	0.00858	CcSEcCtD
Drospirenone—PGR—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.000174	0.00939	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000168	0.00789	CcSEcCtD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—ulcerative colitis	0.000166	0.009	CbGpPWpGaD
Drospirenone—Angiopathy—Budesonide—ulcerative colitis	0.000166	0.00779	CcSEcCtD
Drospirenone—Depression—Mesalazine—ulcerative colitis	0.000165	0.00775	CcSEcCtD
Drospirenone—Haemoglobin—Azathioprine—ulcerative colitis	0.000164	0.0077	CcSEcCtD
Drospirenone—Haemorrhage—Azathioprine—ulcerative colitis	0.000163	0.00766	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000162	0.00764	CcSEcCtD
Drospirenone—PGR—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.000161	0.00869	CbGpPWpGaD
Drospirenone—PGR—Cellular roles of Anthrax toxin—IL1B—ulcerative colitis	0.00016	0.00868	CbGpPWpGaD
Drospirenone—Mental disorder—Budesonide—ulcerative colitis	0.00016	0.00752	CcSEcCtD
Drospirenone—NR3C2—Preimplantation Embryo—CDH1—ulcerative colitis	0.000158	0.00855	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—ulcerative colitis	0.000158	0.00855	CbGpPWpGaD
Drospirenone—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000156	0.00845	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptors—VDR—ulcerative colitis	0.000155	0.00838	CbGpPWpGaD
Drospirenone—Erythema multiforme—Azathioprine—ulcerative colitis	0.000154	0.00724	CcSEcCtD
Drospirenone—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.000154	0.00833	CbGpPWpGaD
Drospirenone—Affect lability—Prednisolone—ulcerative colitis	0.000154	0.00723	CcSEcCtD
Drospirenone—Affect lability—Hydrocortisone—ulcerative colitis	0.00015	0.00706	CcSEcCtD
Drospirenone—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.000149	0.119	CbGdCrCtD
Drospirenone—Haemoglobin—Mesalazine—ulcerative colitis	0.000149	0.00701	CcSEcCtD
Drospirenone—Haemorrhage—Mesalazine—ulcerative colitis	0.000148	0.00698	CcSEcCtD
Drospirenone—Mood swings—Prednisolone—ulcerative colitis	0.000148	0.00696	CcSEcCtD
Drospirenone—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000147	0.118	CbGdCrCtD
Drospirenone—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000147	0.118	CbGdCrCtD
Drospirenone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—ulcerative colitis	0.000147	0.00796	CbGpPWpGaD
Drospirenone—Mood swings—Hydrocortisone—ulcerative colitis	0.000144	0.0068	CcSEcCtD
Drospirenone—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000144	0.115	CbGdCrCtD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CALM3—ulcerative colitis	0.000142	0.0077	CbGpPWpGaD
Drospirenone—PGR—Nuclear Receptors—PPARG—ulcerative colitis	0.000142	0.00766	CbGpPWpGaD
Drospirenone—Testosterone—SLC22A4—ulcerative colitis	0.000141	0.251	CrCbGaD
Drospirenone—Affect lability—Triamcinolone—ulcerative colitis	0.000141	0.00665	CcSEcCtD
Drospirenone—Affect lability—Methylprednisolone—ulcerative colitis	0.000141	0.00663	CcSEcCtD
Drospirenone—Erythema multiforme—Mesalazine—ulcerative colitis	0.00014	0.0066	CcSEcCtD
Drospirenone—NR3C2—Gene Expression—ZFP90—ulcerative colitis	0.000137	0.00742	CbGpPWpGaD
Drospirenone—Mood swings—Triamcinolone—ulcerative colitis	0.000136	0.0064	CcSEcCtD
Drospirenone—Mood swings—Methylprednisolone—ulcerative colitis	0.000136	0.00638	CcSEcCtD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—ulcerative colitis	0.000136	0.00734	CbGpPWpGaD
Drospirenone—Angiopathy—Mesalazine—ulcerative colitis	0.000135	0.00633	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000134	0.00632	CcSEcCtD
Drospirenone—AR—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.000132	0.00716	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.000131	0.00708	CbGpPWpGaD
Drospirenone—Mental disorder—Mesalazine—ulcerative colitis	0.00013	0.00611	CcSEcCtD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.00013	0.00703	CbGpPWpGaD
Drospirenone—Breast disorder—Methylprednisolone—ulcerative colitis	0.000129	0.00609	CcSEcCtD
Drospirenone—Migraine—Betamethasone—ulcerative colitis	0.000128	0.00603	CcSEcCtD
Drospirenone—Migraine—Dexamethasone—ulcerative colitis	0.000128	0.00603	CcSEcCtD
Drospirenone—Affect lability—Betamethasone—ulcerative colitis	0.000128	0.00603	CcSEcCtD
Drospirenone—Affect lability—Dexamethasone—ulcerative colitis	0.000128	0.00603	CcSEcCtD
Drospirenone—Nervous system disorder—Budesonide—ulcerative colitis	0.000127	0.00598	CcSEcCtD
Drospirenone—PTGS2—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000127	0.00686	CbGpPWpGaD
Drospirenone—Skin disorder—Budesonide—ulcerative colitis	0.000126	0.00592	CcSEcCtD
Drospirenone—Mood swings—Betamethasone—ulcerative colitis	0.000123	0.00581	CcSEcCtD
Drospirenone—Mood swings—Dexamethasone—ulcerative colitis	0.000123	0.00581	CcSEcCtD
Drospirenone—AR—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.000122	0.00662	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.00012	0.00564	CcSEcCtD
Drospirenone—Acute coronary syndrome—Prednisolone—ulcerative colitis	0.000119	0.00558	CcSEcCtD
Drospirenone—Myocardial infarction—Prednisolone—ulcerative colitis	0.000118	0.00555	CcSEcCtD
Drospirenone—PGR—Cellular roles of Anthrax toxin—TNF—ulcerative colitis	0.000116	0.0063	CbGpPWpGaD
Drospirenone—PGR—Nuclear signaling by ERBB4—JAK2—ulcerative colitis	0.000116	0.00627	CbGpPWpGaD
Drospirenone—Acute coronary syndrome—Hydrocortisone—ulcerative colitis	0.000116	0.00545	CcSEcCtD
Drospirenone—Nausea—Mercaptopurine—ulcerative colitis	0.000115	0.00543	CcSEcCtD
Drospirenone—Myocardial infarction—Hydrocortisone—ulcerative colitis	0.000115	0.00542	CcSEcCtD
Drospirenone—Skin disorder—Azathioprine—ulcerative colitis	0.000112	0.00529	CcSEcCtD
Drospirenone—PGR—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	0.000112	0.00606	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000112	0.00526	CcSEcCtD
Drospirenone—Nausea—Nicotine—ulcerative colitis	0.000112	0.00526	CcSEcCtD
Drospirenone—Affect lability—Prednisone—ulcerative colitis	0.000112	0.00525	CcSEcCtD
Drospirenone—NR3C2—smooth muscle tissue—ulcerative colitis	0.000112	0.0868	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000109	0.00514	CcSEcCtD
Drospirenone—Acute coronary syndrome—Triamcinolone—ulcerative colitis	0.000109	0.00513	CcSEcCtD
Drospirenone—Acute coronary syndrome—Methylprednisolone—ulcerative colitis	0.000109	0.00512	CcSEcCtD
Drospirenone—Haemoglobin—Prednisolone—ulcerative colitis	0.000109	0.00511	CcSEcCtD
Drospirenone—Myocardial infarction—Triamcinolone—ulcerative colitis	0.000108	0.0051	CcSEcCtD
Drospirenone—Myocardial infarction—Methylprednisolone—ulcerative colitis	0.000108	0.00509	CcSEcCtD
Drospirenone—Haemorrhage—Prednisolone—ulcerative colitis	0.000108	0.00508	CcSEcCtD
Drospirenone—AR—Nuclear Receptors—PPARG—ulcerative colitis	0.000108	0.00584	CbGpPWpGaD
Drospirenone—PGR—epithelium—ulcerative colitis	0.000108	0.0837	CbGeAlD
Drospirenone—Mood swings—Prednisone—ulcerative colitis	0.000108	0.00506	CcSEcCtD
Drospirenone—Haemoglobin—Hydrocortisone—ulcerative colitis	0.000106	0.00499	CcSEcCtD
Drospirenone—Haemorrhage—Hydrocortisone—ulcerative colitis	0.000106	0.00496	CcSEcCtD
Drospirenone—PGR—smooth muscle tissue—ulcerative colitis	0.000104	0.0807	CbGeAlD
Drospirenone—Nervous system disorder—Mesalazine—ulcerative colitis	0.000103	0.00486	CcSEcCtD
Drospirenone—Skin disorder—Mesalazine—ulcerative colitis	0.000102	0.00482	CcSEcCtD
Drospirenone—PTGS2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000102	0.00553	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Azathioprine—ulcerative colitis	9.99e-05	0.0047	CcSEcCtD
Drospirenone—Haemoglobin—Triamcinolone—ulcerative colitis	9.99e-05	0.0047	CcSEcCtD
Drospirenone—Haemoglobin—Methylprednisolone—ulcerative colitis	9.96e-05	0.00469	CcSEcCtD
Drospirenone—Haemorrhage—Triamcinolone—ulcerative colitis	9.94e-05	0.00467	CcSEcCtD
Drospirenone—Haemorrhage—Methylprednisolone—ulcerative colitis	9.91e-05	0.00466	CcSEcCtD
Drospirenone—Acute coronary syndrome—Betamethasone—ulcerative colitis	9.9e-05	0.00466	CcSEcCtD
Drospirenone—Acute coronary syndrome—Dexamethasone—ulcerative colitis	9.9e-05	0.00466	CcSEcCtD
Drospirenone—AR—SIDS Susceptibility Pathways—RUNX3—ulcerative colitis	9.85e-05	0.00533	CbGpPWpGaD
Drospirenone—Myocardial infarction—Dexamethasone—ulcerative colitis	9.84e-05	0.00463	CcSEcCtD
Drospirenone—Myocardial infarction—Betamethasone—ulcerative colitis	9.84e-05	0.00463	CcSEcCtD
Drospirenone—Mental disorder—Hydrocortisone—ulcerative colitis	9.24e-05	0.00435	CcSEcCtD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CALM3—ulcerative colitis	9.21e-05	0.00498	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Mesalazine—ulcerative colitis	9.1e-05	0.00428	CcSEcCtD
Drospirenone—Haemoglobin—Dexamethasone—ulcerative colitis	9.06e-05	0.00426	CcSEcCtD
Drospirenone—Haemoglobin—Betamethasone—ulcerative colitis	9.06e-05	0.00426	CcSEcCtD
Drospirenone—BCHE—Peptide hormone metabolism—GHRL—ulcerative colitis	9.03e-05	0.00489	CbGpPWpGaD
Drospirenone—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	9.02e-05	0.0721	CbGdCrCtD
Drospirenone—Haemorrhage—Dexamethasone—ulcerative colitis	9.01e-05	0.00424	CcSEcCtD
Drospirenone—Haemorrhage—Betamethasone—ulcerative colitis	9.01e-05	0.00424	CcSEcCtD
Drospirenone—Angiopathy—Methylprednisolone—ulcerative colitis	8.99e-05	0.00423	CcSEcCtD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—ulcerative colitis	8.94e-05	0.00484	CbGpPWpGaD
Drospirenone—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	8.87e-05	0.0709	CbGdCrCtD
Drospirenone—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	8.87e-05	0.0709	CbGdCrCtD
Drospirenone—Megestrol acetate—ABCB1—ulcerative colitis	8.84e-05	0.157	CrCbGaD
Drospirenone—NR3C2—digestive system—ulcerative colitis	8.81e-05	0.0685	CbGeAlD
Drospirenone—Depression—Prednisone—ulcerative colitis	8.72e-05	0.0041	CcSEcCtD
Drospirenone—Mental disorder—Methylprednisolone—ulcerative colitis	8.69e-05	0.00408	CcSEcCtD
Drospirenone—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	8.67e-05	0.0693	CbGdCrCtD
Drospirenone—PTGS2—Spinal Cord Injury—MIF—ulcerative colitis	8.62e-05	0.00467	CbGpPWpGaD
Drospirenone—Acute coronary syndrome—Prednisone—ulcerative colitis	8.62e-05	0.00405	CcSEcCtD
Drospirenone—AR—epithelium—ulcerative colitis	8.57e-05	0.0667	CbGeAlD
Drospirenone—Myocardial infarction—Prednisone—ulcerative colitis	8.57e-05	0.00403	CcSEcCtD
Drospirenone—AR—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	8.53e-05	0.00461	CbGpPWpGaD
Drospirenone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	8.46e-05	0.00458	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—ulcerative colitis	8.45e-05	0.00457	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—ZFP90—ulcerative colitis	8.36e-05	0.00452	CbGpPWpGaD
Drospirenone—PGR—lymphoid tissue—ulcerative colitis	8.29e-05	0.0645	CbGeAlD
Drospirenone—AR—smooth muscle tissue—ulcerative colitis	8.26e-05	0.0643	CbGeAlD
Drospirenone—PTGS2—Overview of nanoparticle effects—CXCL8—ulcerative colitis	8.24e-05	0.00446	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—ulcerative colitis	8.22e-05	0.00445	CbGpPWpGaD
Drospirenone—Angiopathy—Betamethasone—ulcerative colitis	8.18e-05	0.00385	CcSEcCtD
Drospirenone—Angiopathy—Dexamethasone—ulcerative colitis	8.18e-05	0.00385	CcSEcCtD
Drospirenone—PGR—Generic Transcription Pathway—NR5A2—ulcerative colitis	7.97e-05	0.00431	CbGpPWpGaD
Drospirenone—Haemoglobin—Prednisone—ulcerative colitis	7.89e-05	0.00371	CcSEcCtD
Drospirenone—Haemorrhage—Prednisone—ulcerative colitis	7.85e-05	0.00369	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	7.77e-05	0.00365	CcSEcCtD
Drospirenone—Nausea—Budesonide—ulcerative colitis	7.7e-05	0.00362	CcSEcCtD
Drospirenone—AR—Notch-mediated HES/HEY network—JAK2—ulcerative colitis	7.61e-05	0.00412	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	7.47e-05	0.00404	CbGpPWpGaD
Drospirenone—Nervous system disorder—Hydrocortisone—ulcerative colitis	7.35e-05	0.00346	CcSEcCtD
Drospirenone—PTGS2—C-MYB transcription factor network—MPO—ulcerative colitis	7.34e-05	0.00397	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—HNF4A—ulcerative colitis	7.31e-05	0.00396	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	7.3e-05	0.00343	CcSEcCtD
Drospirenone—Skin disorder—Hydrocortisone—ulcerative colitis	7.28e-05	0.00342	CcSEcCtD
Drospirenone—AR—Notch-mediated HES/HEY network—CD4—ulcerative colitis	7.21e-05	0.0039	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—MAML2—ulcerative colitis	7.12e-05	0.00385	CbGpPWpGaD
Drospirenone—Angiopathy—Prednisone—ulcerative colitis	7.12e-05	0.00335	CcSEcCtD
Drospirenone—PTGS2—Selenium Micronutrient Network—MPO—ulcerative colitis	7.07e-05	0.00382	CbGpPWpGaD
Drospirenone—Nervous system disorder—Methylprednisolone—ulcerative colitis	6.91e-05	0.00325	CcSEcCtD
Drospirenone—Mental disorder—Prednisone—ulcerative colitis	6.88e-05	0.00323	CcSEcCtD
Drospirenone—Nausea—Azathioprine—ulcerative colitis	6.87e-05	0.00323	CcSEcCtD
Drospirenone—Skin disorder—Methylprednisolone—ulcerative colitis	6.84e-05	0.00322	CcSEcCtD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	6.83e-05	0.0037	CbGpPWpGaD
Drospirenone—BCHE—smooth muscle tissue—ulcerative colitis	6.72e-05	0.0523	CbGeAlD
Drospirenone—AR—lymphoid tissue—ulcerative colitis	6.6e-05	0.0514	CbGeAlD
Drospirenone—NR3C2—liver—ulcerative colitis	6.56e-05	0.051	CbGeAlD
Drospirenone—AR—digestive system—ulcerative colitis	6.52e-05	0.0507	CbGeAlD
Drospirenone—PTGS2—Selenium Micronutrient Network—PTGS1—ulcerative colitis	6.51e-05	0.00352	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	6.47e-05	0.00304	CcSEcCtD
Drospirenone—AR—Gene Expression—ZFP90—ulcerative colitis	6.37e-05	0.00344	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—ulcerative colitis	6.32e-05	0.00342	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—NR5A2—ulcerative colitis	6.3e-05	0.00341	CbGpPWpGaD
Drospirenone—Nervous system disorder—Betamethasone—ulcerative colitis	6.28e-05	0.00295	CcSEcCtD
Drospirenone—Nervous system disorder—Dexamethasone—ulcerative colitis	6.28e-05	0.00295	CcSEcCtD
Drospirenone—Nausea—Mesalazine—ulcerative colitis	6.26e-05	0.00294	CcSEcCtD
Drospirenone—AR—Generic Transcription Pathway—NR5A2—ulcerative colitis	6.07e-05	0.00329	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	5.78e-05	0.00272	CcSEcCtD
Drospirenone—PTGS2—Overview of nanoparticle effects—TNF—ulcerative colitis	5.74e-05	0.0031	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—ulcerative colitis	5.67e-05	0.00307	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—FCGR2A—ulcerative colitis	5.66e-05	0.00306	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—ulcerative colitis	5.62e-05	0.00304	CbGpPWpGaD
Drospirenone—AR—Notch-mediated HES/HEY network—STAT3—ulcerative colitis	5.59e-05	0.00302	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MUC3A—ulcerative colitis	5.56e-05	0.00301	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	5.53e-05	0.0026	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Betamethasone—ulcerative colitis	5.53e-05	0.0026	CcSEcCtD
Drospirenone—Spironolactone—ABCB1—ulcerative colitis	5.5e-05	0.0975	CrCbGaD
Drospirenone—Nervous system disorder—Prednisone—ulcerative colitis	5.47e-05	0.00257	CcSEcCtD
Drospirenone—Skin disorder—Prednisone—ulcerative colitis	5.42e-05	0.00255	CcSEcCtD
Drospirenone—PTGS2—epithelium—ulcerative colitis	5.37e-05	0.0418	CbGeAlD
Drospirenone—Norethindrone—ALB—ulcerative colitis	5.35e-05	0.0948	CrCbGaD
Drospirenone—BCHE—digestive system—ulcerative colitis	5.31e-05	0.0413	CbGeAlD
Drospirenone—PTGS2—smooth muscle tissue—ulcerative colitis	5.18e-05	0.0403	CbGeAlD
Drospirenone—Norethindrone—ABCB1—ulcerative colitis	5.11e-05	0.0905	CrCbGaD
Drospirenone—Methyltestosterone—ALB—ulcerative colitis	5.08e-05	0.0901	CrCbGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—ulcerative colitis	4.98e-05	0.0027	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL10—ulcerative colitis	4.86e-05	0.00263	CbGpPWpGaD
Drospirenone—AR—liver—ulcerative colitis	4.86e-05	0.0378	CbGeAlD
Drospirenone—PTGS2—Overview of nanoparticle effects—IL6—ulcerative colitis	4.63e-05	0.0025	CbGpPWpGaD
Drospirenone—Nausea—Prednisolone—ulcerative colitis	4.56e-05	0.00214	CcSEcCtD
Drospirenone—NR3C2—Generic Transcription Pathway—VDR—ulcerative colitis	4.55e-05	0.00246	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—ulcerative colitis	4.54e-05	0.00246	CbGpPWpGaD
Drospirenone—Nausea—Hydrocortisone—ulcerative colitis	4.45e-05	0.00209	CcSEcCtD
Drospirenone—PGR—Generic Transcription Pathway—HNF4A—ulcerative colitis	4.45e-05	0.00241	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—RELA—ulcerative colitis	4.42e-05	0.00239	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—CALM3—ulcerative colitis	4.41e-05	0.00239	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—MAML2—ulcerative colitis	4.34e-05	0.00235	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	4.31e-05	0.00233	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	4.26e-05	0.00231	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—MMP1—ulcerative colitis	4.25e-05	0.0023	CbGpPWpGaD
Drospirenone—Nausea—Triamcinolone—ulcerative colitis	4.19e-05	0.00197	CcSEcCtD
Drospirenone—Nausea—Methylprednisolone—ulcerative colitis	4.18e-05	0.00197	CcSEcCtD
Drospirenone—PTGS2—lymphoid tissue—ulcerative colitis	4.14e-05	0.0322	CbGeAlD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—ulcerative colitis	4.1e-05	0.00222	CbGpPWpGaD
Drospirenone—PTGS2—digestive system—ulcerative colitis	4.09e-05	0.0318	CbGeAlD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—ulcerative colitis	4.09e-05	0.00221	CbGpPWpGaD
Drospirenone—BCHE—liver—ulcerative colitis	3.95e-05	0.0308	CbGeAlD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	3.93e-05	0.00212	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—JAK2—ulcerative colitis	3.91e-05	0.00211	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NR5A2—ulcerative colitis	3.84e-05	0.00208	CbGpPWpGaD
Drospirenone—Nausea—Dexamethasone—ulcerative colitis	3.8e-05	0.00179	CcSEcCtD
Drospirenone—Nausea—Betamethasone—ulcerative colitis	3.8e-05	0.00179	CcSEcCtD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ulcerative colitis	3.8e-05	0.00206	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—CRP—ulcerative colitis	3.72e-05	0.00201	CbGpPWpGaD
Drospirenone—Hydrocortisone—ABCB1—ulcerative colitis	3.65e-05	0.0647	CrCbGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	3.64e-05	0.00197	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ulcerative colitis	3.63e-05	0.00197	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—HNF4A—ulcerative colitis	3.52e-05	0.0019	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MAML2—ulcerative colitis	3.43e-05	0.00186	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—ICAM1—ulcerative colitis	3.42e-05	0.00185	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—CDH1—ulcerative colitis	3.41e-05	0.00185	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—HNF4A—ulcerative colitis	3.39e-05	0.00184	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—CALM3—ulcerative colitis	3.38e-05	0.00183	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—STAT3—ulcerative colitis	3.35e-05	0.00181	CbGpPWpGaD
Drospirenone—Nausea—Prednisone—ulcerative colitis	3.31e-05	0.00156	CcSEcCtD
Drospirenone—AR—Generic Transcription Pathway—MAML2—ulcerative colitis	3.31e-05	0.00179	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	3.2e-05	0.00173	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—PPARG—ulcerative colitis	3.17e-05	0.00172	CbGpPWpGaD
Drospirenone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	3.1e-05	0.00168	CbGpPWpGaD
Drospirenone—PTGS2—liver—ulcerative colitis	3.05e-05	0.0237	CbGeAlD
Drospirenone—Progesterone—ABCB1—ulcerative colitis	2.97e-05	0.0527	CrCbGaD
Drospirenone—Testosterone—ALB—ulcerative colitis	2.95e-05	0.0522	CrCbGaD
Drospirenone—AR—Gene Expression—NR5A2—ulcerative colitis	2.92e-05	0.00158	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—ALB—ulcerative colitis	2.85e-05	0.00154	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	2.83e-05	0.00153	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TLR4—ulcerative colitis	2.82e-05	0.00153	CbGpPWpGaD
Drospirenone—Testosterone—ABCB1—ulcerative colitis	2.81e-05	0.0499	CrCbGaD
Drospirenone—PGR—Generic Transcription Pathway—VDR—ulcerative colitis	2.77e-05	0.0015	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MUC2—ulcerative colitis	2.72e-05	0.00147	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—ICAM1—ulcerative colitis	2.7e-05	0.00146	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	2.66e-05	0.00144	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	2.65e-05	0.00143	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CD4—ulcerative colitis	2.61e-05	0.00141	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IFNG—ulcerative colitis	2.6e-05	0.00141	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—RELA—ulcerative colitis	2.57e-05	0.00139	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	2.55e-05	0.00138	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—ADCY5—ulcerative colitis	2.45e-05	0.00133	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	2.45e-05	0.00133	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—NFKB1—ulcerative colitis	2.44e-05	0.00132	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	2.38e-05	0.00129	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SEL1L—ulcerative colitis	2.36e-05	0.00128	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.33e-05	0.00126	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL1B—ulcerative colitis	2.32e-05	0.00125	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CHP1—ulcerative colitis	2.27e-05	0.00123	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—VDR—ulcerative colitis	2.19e-05	0.00119	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	2.16e-05	0.00117	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—HNF4A—ulcerative colitis	2.14e-05	0.00116	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.12e-05	0.00115	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—VDR—ulcerative colitis	2.11e-05	0.00114	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MAML2—ulcerative colitis	2.09e-05	0.00113	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	2.06e-05	0.00111	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.02e-05	0.0011	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—IL6—ulcerative colitis	2e-05	0.00108	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—DLD—ulcerative colitis	1.96e-05	0.00106	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCR1—ulcerative colitis	1.95e-05	0.00105	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—PPARG—ulcerative colitis	1.93e-05	0.00105	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	1.91e-05	0.00103	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CHP1—ulcerative colitis	1.86e-05	0.00101	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—TNF—ulcerative colitis	1.85e-05	0.001	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	1.83e-05	0.000992	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	1.83e-05	0.000989	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	1.73e-05	0.000936	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL20—ulcerative colitis	1.71e-05	0.000925	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—GHRL—ulcerative colitis	1.71e-05	0.000923	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.69e-05	0.000912	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	1.68e-05	0.000911	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	1.68e-05	0.000907	CbGpPWpGaD
Drospirenone—AR—Gene Expression—HNF4A—ulcerative colitis	1.63e-05	0.000884	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GNA12—ulcerative colitis	1.61e-05	0.00087	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MAML2—ulcerative colitis	1.59e-05	0.000861	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.57e-05	0.000852	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CHP1—ulcerative colitis	1.56e-05	0.000844	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PPARG—ulcerative colitis	1.53e-05	0.000827	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCR2—ulcerative colitis	1.52e-05	0.000825	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL6—ulcerative colitis	1.49e-05	0.000808	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SEL1L—ulcerative colitis	1.48e-05	0.0008	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—PPARG—ulcerative colitis	1.47e-05	0.000797	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.46e-05	0.000791	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCR6—ulcerative colitis	1.43e-05	0.000775	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	1.43e-05	0.000771	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.39e-05	0.000751	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAML2—ulcerative colitis	1.36e-05	0.000735	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	1.36e-05	0.000735	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—DLD—ulcerative colitis	1.35e-05	0.000728	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—VDR—ulcerative colitis	1.34e-05	0.000722	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	1.33e-05	0.00072	CbGpPWpGaD
Drospirenone—PTGS2—Disease—LTF—ulcerative colitis	1.33e-05	0.000718	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTGER4—ulcerative colitis	1.26e-05	0.000683	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	1.17e-05	0.000635	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.16e-05	0.00063	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GHRL—ulcerative colitis	1.15e-05	0.000625	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CALM3—ulcerative colitis	1.12e-05	0.000605	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RIPK2—ulcerative colitis	1.1e-05	0.000596	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	1.07e-05	0.000581	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MMP1—ulcerative colitis	1.06e-05	0.000574	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.03e-05	0.00056	CbGpPWpGaD
Drospirenone—AR—Gene Expression—VDR—ulcerative colitis	1.02e-05	0.00055	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	9.7e-06	0.000525	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADRB2—ulcerative colitis	9.56e-06	0.000517	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS1—ulcerative colitis	9.46e-06	0.000512	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SLC11A1—ulcerative colitis	9.45e-06	0.000512	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PPARG—ulcerative colitis	9.31e-06	0.000504	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9.3e-06	0.000503	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	9.05e-06	0.00049	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CALM3—ulcerative colitis	8.51e-06	0.000461	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAML2—ulcerative colitis	8.5e-06	0.00046	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.14e-06	0.00044	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADCY5—ulcerative colitis	8.11e-06	0.000439	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	7.98e-06	0.000432	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.12e-06	0.000385	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPARG—ulcerative colitis	7.09e-06	0.000384	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CALM3—ulcerative colitis	7e-06	0.000379	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CXCL8—ulcerative colitis	6.82e-06	0.000369	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ABCB1—ulcerative colitis	6.62e-06	0.000358	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PTGS1—ulcerative colitis	6.51e-06	0.000352	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.4e-06	0.000346	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ADCY5—ulcerative colitis	6.18e-06	0.000334	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CALM3—ulcerative colitis	5.86e-06	0.000317	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ADCY5—ulcerative colitis	5.08e-06	0.000275	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JAK2—ulcerative colitis	5.06e-06	0.000274	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RELA—ulcerative colitis	4.9e-06	0.000265	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL8—ulcerative colitis	4.62e-06	0.00025	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARG—ulcerative colitis	4.61e-06	0.000249	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCB1—ulcerative colitis	4.56e-06	0.000247	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL2—ulcerative colitis	4.41e-06	0.000239	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ADCY5—ulcerative colitis	4.25e-06	0.00023	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP9—ulcerative colitis	4.18e-06	0.000226	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALB—ulcerative colitis	4.14e-06	0.000224	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NFKB1—ulcerative colitis	4.13e-06	0.000224	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STAT3—ulcerative colitis	3.71e-06	0.000201	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—ulcerative colitis	3.62e-06	0.000196	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFB1—ulcerative colitis	3.44e-06	0.000186	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARG—ulcerative colitis	3.17e-06	0.000172	CbGpPWpGaD
Drospirenone—PTGS2—Disease—JAK2—ulcerative colitis	3.16e-06	0.000171	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD4—ulcerative colitis	3e-06	0.000162	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALB—ulcerative colitis	2.85e-06	0.000154	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—ulcerative colitis	2.83e-06	0.000153	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—ulcerative colitis	2.59e-06	0.00014	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STAT3—ulcerative colitis	2.32e-06	0.000126	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFB1—ulcerative colitis	2.15e-06	0.000117	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—ulcerative colitis	1.62e-06	8.78e-05	CbGpPWpGaD
